Difference between revisions of "Moclobemide-imipramine"

From Psychiatrienet
Jump to: navigation, search
(Undo revision 8725 by Zoe (talk))
Line 3: Line 3:
 
| to = imipramine  
 
| to = imipramine  
 
| stop =  
 
| stop =  
{{generaldecrease25p3d}}
+
{{stopMoclobemide}}
{{24Hwashout}}
 
 
| start =  
 
| start =  
{{generalstart}
+
* '''Day 9:''' start administration of imipramine the next day in a normal dosage of 25-75 mg/day.
 
|info=
 
|info=
 
* Because of short halve life of moclobemide after stopping, the next antidepressant can start next day.
 
* Because of short halve life of moclobemide after stopping, the next antidepressant can start next day.

Revision as of 10:05, 20 June 2016

Moclobemide
Type Antidepressant
Group MAO-I
links
Medscape Moclobemide
PubChem 4235
PubMed Moclobemide
Kompas (Dutch) Moclobemide
Wikipedia Moclobemide
Imipramine
Type Antidepressant
Group TCA
links
Medscape Imipramine
PubChem 3696
PubMed Imipramine
Kompas (Dutch) Imipramine
Wikipedia Imipramine

Switch medication from moclobemide to imipramine.

Nietinrijdenbord.png Stop moclobemide
  • Before day 1: gradually reduce dosage of moclobemide to a maximum of 300 mg/day.
  • Day 1: reduce the dosage of moclobemide to 150 mg/day.
  • Day 8: stop administration of moclobemide.
Eenrichtingbord.png Start imipramine
  • Day 9: start administration of imipramine the next day in a normal dosage of 25-75 mg/day.
Infobord.png More information
  • Because of short halve life of moclobemide after stopping, the next antidepressant can start next day.
  • No wash-out period is needed.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.